Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
149.66
-9.17 (-5.77%)
At close: Aug 26, 2026, 4:00 PM EDT
147.66
-2.00 (-1.34%)
After-hours: Aug 26, 2026, 7:59 PM EDT
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales | 2.06B | 2.08B | 1.82B | 2.11B | 2.96B | 3.03B | 3.11B | 4.96B | |||||||||||||||
| Product Sales Growth | -30.22% | -31.18% | -41.52% | -57.47% | -39.64% | -39.56% | -53.40% | -43.42% | |||||||||||||||
| Grant and Collaboration | 164.00M | 141.00M | 126.00M | 121.00M | 120.00M | 149.00M | 127.00M | 117.00M | |||||||||||||||
| Grant and Collaboration Growth | 36.67% | -5.37% | -0.79% | 3.42% | -19.46% | 4.20% | -28.25% | -69.53% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 1.19B | 1.21B | 1.17B | 1.15B | 1.58B | 1.66B | 1.73B | 2.28B | |||||||
| United States Growth | -24.89% | -27.16% | -32.50% | -49.58% | -20.01% | -8.91% | 0.35% | 17.52% | |||||||
| Rest of World | 570.00M | 588.00M | 603.00M | 653.00M | 802.00M | 798.00M | 810.00M | 1.79B | |||||||
| Rest of World Growth | -28.93% | -26.32% | -25.56% | -63.48% | -63.63% | -66.94% | -77.49% | -53.39% | |||||||
| Europe | 305.00M | 289.00M | 50.00M | 308.00M | 573.00M | 573.00M | 573.00M | 895.00M | |||||||
| Europe Growth | -46.77% | -49.56% | -91.27% | -65.59% | -20.08% | -26.25% | -57.65% | -69.76% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and Development | 2.88B | 2.93B | 3.13B | 3.48B | 3.82B | 4.34B | 4.54B | 4.83B | |||||||||||||||
| Research and Development Growth | -24.61% | -32.54% | -31.06% | -27.93% | -21.34% | -9.23% | -6.23% | 3.81% | |||||||||||||||
| Selling, General, and Administrative | 965.00M | 979.00M | 1.02B | 1.06B | 1.07B | 1.11B | 1.17B | 1.29B | |||||||||||||||
| Selling, General, and Administrative Growth | -10.15% | -11.96% | -13.29% | -17.94% | -26.13% | -26.75% | -24.21% | -11.07% |